Impact of Oxaliplatin-based chemotherapy on the haemoglobin levels: A retrospective analysis in patients with colorectal cancer

被引：0
|
作者：
Queralt, Bernardo [1 ]
Juez, Ignacio [1 ]
Hernandez, Xavier [1 ]
Vinas, Gemma [1 ]
Rubio, Jordi [1 ]
Soler, Francesc [1 ]
Monleon, Antonio [2 ]
Colomer, Ramon [1 ]
机构：
[1] Hosp Josep Trueta, Inst Catala Oncol, Dept Oncol, Girona, Spain
[2] Univ Barcelona, Dept Stat, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：86 / 86
页数：1
相关论文
共 50 条
  • [21] Validation of Genetic Markers Associated with Survival in Colorectal Cancer Patients Treated with Oxaliplatin-Based Chemotherapy
    Park, Hanla A.
    Seibold, Petra
    Edelmann, Dominic
    Benner, Axel
    Canzian, Federico
    Alwers, Elizabeth
    Jansen, Lina
    Schneider, Martin
    Hoffmeister, Michael
    Brenner, Hermann
    Chang-Claude, Jenny
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (02) : 352 - 361
  • [22] Severe hepatic sinusoidal obstruction associated with oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer
    Rubbia-Brandt, L
    Audard, V
    Sartoretti, P
    Roth, AD
    Brezault, C
    Le Charpentier, M
    Dousset, B
    Morel, P
    Soubrane, O
    Chaussade, S
    Mentha, G
    Terris, B
    ANNALS OF ONCOLOGY, 2004, 15 (03) : 460 - 466
  • [23] Splenomegaly During Oxaliplatin-based Chemotherapy for Colorectal Carcinoma
    Jung, Eun-Joo
    Ryu, Chun-Geun
    Kim, Gangmi
    Kim, Su Ran
    Park, Hee Sun
    Kim, Young Jun
    Hwang, Dae-Yong
    ANTICANCER RESEARCH, 2012, 32 (08) : 3357 - 3362
  • [24] Outcomes in patients (pts) with colorectal cancer (CRC) treated with oxaliplatin-based chemotherapy (OC) following prior oxaliplatin exposure
    Bhadkamkar, Nishin Anil
    Sahin, Ibrahim Halil
    Shen, Yehua
    Hassabo, Hesham Mohamed
    Kee, Bryan K.
    Hassan, Manal
    Garrett, Chris R.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [25] Outcome in disappearing colorectal cancer liver metastases during oxaliplatin-based chemotherapy
    Ono, Tomojiro
    Ishida, Hideyuki
    Kumamoto, Kensuke
    Okada, Norimichi
    Ishibashi, Keiichiro
    ONCOLOGY LETTERS, 2012, 4 (05) : 905 - 909
  • [26] Functional Analysis of SNPs in the ERCC5 Promoter in Advanced Colorectal Cancer Patients Treated With Oxaliplatin-Based Chemotherapy
    Chen, Jianfang
    Luo, Xi
    Xie, Ganfeng
    Chen, Keli
    Jiang, Heng
    Pan, Feng
    Li, Jianjun
    Ruan, Zhihua
    Pang, Xueli
    Liang, Houjie
    MEDICINE, 2016, 95 (19)
  • [27] Efficacy of Oxaliplatin-Based Chemotherapy in Curatively Resected Colorectal Cancer with Liver Metastasis
    Kim, Hye Ryun
    Min, Byung Soh
    Kim, Jin Soo
    Shin, Sang Joon
    Ahn, Joong Bae
    Rho, Jae Kyung
    Kim, Nam Kyu
    Rha, Sun Young
    ONCOLOGY, 2011, 81 (3-4) : 175 - 183
  • [28] USE OF OXALIPLATIN-BASED CHEMOTHERAPY IN PATIENTS WITH METASTATIC COLORECTAL CANCER (MCRC): A POST-HOC ANALYSIS OF THE GLUTOX STUDY
    Benoit, Samson
    Pierre, Dube
    Nathalie, Aucoin
    Rafal, Wierzbicki
    Jean, Maroun
    Richard, Letourneau
    Eric, Chen
    Danielle, Charpentier
    Felix, Couture
    Mark, Vincent
    Jean, Lepine
    Pierre, Whitlock
    Karine, Alloul
    Francois, Leblond
    Wei, Zhou
    Petr, Kavan
    ANNALS OF ONCOLOGY, 2014, 25
  • [29] Irinotecan- vs oxaliplatin-based regimens for neoadjuvant chemotherapy in colorectal liver metastasis patients: A retrospective study
    Liu, Wei
    Chen, Feng-Lin
    Wang, Kun
    Bao, Quan
    Wang, Hong-Wei
    Jin, Ke-Min
    Xing, Bao-Cai
    WORLD JOURNAL OF GASTROINTESTINAL SURGERY, 2022, 14 (09): : 904 - 917
  • [30] Real-world impact on overall survival of oxaliplatin-based adjuvant chemotherapy in older patients with colorectal cancer in Mexico.
    Herrera, Marytere
    Garcia, Elizabeth
    Diaz, Consuelo
    Ruiz-Garcia, Erika
    Adame, Sayako Miyagui
    Hernandez, Stefan Zilli
    Lopez, Mextli
    Carbajal, Berenice
    Ruiz, German Calderillo
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 61 - 61
12345